Related Experiment Videos
[Studies on hypoglycemic effect of xuetangping]
Summary
Xuetangping (XTP) effectively lowers blood sugar and increases liver glycogen in diabetic rats. This traditional Chinese medicine also reduces mortality, offering a potential therapeutic for diabetes.
Area of Science:
- Pharmacology
- Biochemistry
- Diabetology
Context:
- Alloxan-induced diabetes in rat models is a standard method for studying anti-diabetic compounds.
- Xuetangping (XTP) is a traditional Chinese medicine with potential therapeutic properties.
- Elevated serum glucose and depleted liver glycogen are key indicators of diabetes.
Purpose:
- To investigate the anti-diabetic effects of Xuetangping (XTP).
- To evaluate XTP's impact on serum glucose levels and liver glycogen content in diabetic rats.
- To assess XTP's efficacy in reducing mortality associated with alloxan-induced diabetes.
Summary:
- Xuetangping (XTP) administration at 1.5 g/kg for 14 days normalized serum glucose levels in diabetic rats.
- Treatment with XTP significantly increased liver glycogen content in diabetic rats by day 14.
- A lower dose of XTP (0.75 g/kg for 7 days) prevented the rise in serum glucose induced by alloxan.
- XTP treatment also demonstrated a notable reduction in the mortality rate of diabetic rats.
Impact:
- Xuetangping (XTP) shows significant potential as a therapeutic agent for managing diabetes.
- The findings support the traditional use of XTP and warrant further investigation into its mechanisms of action.
- This study provides evidence for XTP's role in improving glycemic control and hepatic glycogen storage.